- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rxsight Inc (RXST)
Track today's live Rxsight (RXST) share price, performance and key data on this page with our current NASDAQ:RXST stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Rxsight share price on the NASDAQ exchange. Use the dropdown to switch exchange for the RXST share price, head to our technical summary section, which provides analysis on Rxsight share price buy/sell indicators using real-time data (or discuss the Rxsight (RXST) stock price today with other investors in the Rxsight NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:RXST share price (ISIN: US78349D1072) to enhance your trading decisions with our free investment tools and resources.
What Is the Rxsight Inc Share Price Today?
The Rxsight share price today is 6.16.
What Is the Stock Symbol for Rxsight Inc
The stock symbol (or 'ticker') for Rxsight Inc is "RXST."
What Stock Exchange Does Rxsight Inc Trade On?
Rxsight Inc is listed and trades on the NASDAQ stock exchange.
Is Rxsight Inc a Good Stock to Buy?
Determining whether Rxsight (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:RXST share price (ISIN: US78349D1072) to enhance your trading decisions with our free investment tools and resources.
What Is the Rxsight Inc Share Price Today?
The Rxsight share price today is 6.16.
What Is the Stock Symbol for Rxsight Inc
The stock symbol (or 'ticker') for Rxsight Inc is "RXST."
What Stock Exchange Does Rxsight Inc Trade On?
Rxsight Inc is listed and trades on the NASDAQ stock exchange.
Is Rxsight Inc a Good Stock to Buy?
Determining whether Rxsight (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.10
6.66
52 wk Range
4.48
13.22
RXST is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.106.66
52 wk Range
4.4813.22
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RXST Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
7.79
Upside
+26.42%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
7 Hold
2 Sell
Ratings:
10 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 7.79
(+26.42% Upside)
Rxsight Inc Earnings Call Summary for Q2/2026
- RxSight posted Q2 2026 adjusted EPS loss of $0.11, beating estimates by $0.25, with revenue of $33.74M exceeding forecasts by 4.75%.
- Core product revenue fell 19% YoY to $27.2M amid competitive pressures; LAL unit volumes declined 9% despite $6.5M Alcon collaboration boost.
- Company withdrew full-year 2026 guidance to reassess commercial model; plans to double U.S. sales team and resume guidance in early 2027.
- Gross margin excluding Alcon dropped 370 bps to 71.2%; cash position stands at $209M plus $60M post-quarter Alcon payment received.
- Shares fell 2.23% after-hours to $6.15 as investors weighed guidance withdrawal against earnings beat and ongoing utilization challenges.
Last Updated: 05/08/2026, 22:16
Read Full TranscriptEarnings
Latest Release
05/08/2026
EPS / Forecast
-0.11 / -0.36
Revenue / Forecast
33.74M / 32.21M
Compare RXST to Peers and Sector
Metrics to compare | RXST | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRXSTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.5x | −2.1x | −0.3x | |
PEG Ratio | 0.13 | −0.26 | 0.00 | |
Price/Book | 1.0x | 3.2x | 2.6x | |
Price / LTM Sales | 2.0x | 3.0x | 3.1x | |
Upside (Analyst Target) | 9.6% | 12.8% | 48.5% | |
Fair Value Upside | Unlock | 3.6% | 6.3% | Unlock |
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company’s RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Rxsight (NASDAQ: RXST) Share Price Today?
The Rxsight stock price today is 6.16 USD.
What Stock Exchange Does Rxsight (RXST) Trade On?
Rxsight is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Rxsight?
The stock symbol (also called a 'ticker') for Rxsight is "RXST."
What Is the Current Rxsight Market Capitalisation?
As of today, Rxsight (NASDAQ: RXST) market cap is 256.21M USD.
What Is Rxsight's (RXST) Earnings Per Share (TTM)?
The Rxsight EPS is currently -1.14 (Trailing Twelve Months).
When Is the Next Rxsight Earnings Date?
Rxsight's next earnings report will be released on 11/11/2026.
Is RXST a Buy or Sell From a Technical Analyst Perspective?
Based on today's Rxsight moving averages and other technical indicators, the daily buy/sell signal for RXST stock is Sell.
How Many Times Has Rxsight Stock Split?
Rxsight has split 0 times. (See the RXST stock split history page for full effective split date and price information.)
How Many Employees Does Rxsight Have?
Rxsight has 461 employees, based on their latest Companies House report.
What is the current trading status of Rxsight (NASDAQ: RXST)?
As of 20/08/2026, Rxsight (RXST) is trading at a share price of 6.16 USD, with a previous close of 6.16 USD. The stock has fluctuated within a day range of 6.10 USD to 6.66 USD, while its 52-week range spans from 4.48 USD to 13.22 USD.
What Is Rxsight (RXST) Price Target According to Analysts?
The average 12-month price target for Rxsight is 7.79 USD, with a high estimate of 11 USD and a low estimate of 6 USD. 1 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +26.42% Upside potential.
What Is the RXST Premarket Price?
RXST's last pre-market stock price is 6.20 USD. The pre-market share volume is 890.00, and the stock has decreased by 0.04, or 0.65%.
What Is the RXST After Hours Price?
RXST's last after hours stock price is 6.32 USD, the stock has decreased by 0.16, or 2.60%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.